WA People
BILL · 2017–18 SESSION · LATEST VERSION SSB 5995

SB 5995: Prescription drug prices

Protecting consumers and purchasers from excessive increases in prescription drug prices.

Summary

  • Directs the Washington State Institute for Public Policy (WSIPP) to conduct a study on prescription drug price increases, and report policy recommendations to the appropriate legislative Committees

From the Senate Bill Report (SB 5995), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee
  1. IntroducedJan 8, 2018
  2. Out of committeestopped here
  3. Passed Senate
  4. Passed House
  5. Governor
  6. Law
Prime sponsor
Karen Keiser (D-33)
Introduced
January 8, 2018 in the Senate
Last action
February 2, 2018
Companion bill
HB 2556
Versions
SB 5995, SSB 5995

AN ACT Relating to protecting consumers and purchasers from excessive increases in prescription drug prices;

Sponsors

Prime sponsor: Karen Keiser (D-33)

10 co-sponsors (10 Democrats, 0 Republicans)

Jamie Pedersen D-43Christine Rolfes D-23Kevin Van De Wege D-24Marko Liias D-21Senator D-22Steve Conway D-29Maralyn Chase D-32Rebecca Saldaña D-37Patty Kuderer D-48Bob Hasegawa D-11

Votes

No recorded floor votes. This measure never reached a floor vote.

History

  1. Referred to Ways & Means. (SSB 5995)
  2. Referred to Ways & Means.
  3. And refer to Ways & Means. (SSB 5995)
  4. HLTC - Majority; 1st substitute bill be substituted, do pass. (SSB 5995)
  5. Minority; without recommendation. (SSB 5995)
  6. Minority; without recommendation.
  7. HLTC - Majority; 1st substitute bill be substituted, do pass.
  8. And refer to Ways & Means.
  9. First reading, referred to Health & Long Term Care.
  10. Prefiled for introduction.

SB 5995 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page